Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
oleh: Yuki Ikeda, Michihiro Ono, Ginji Ohmori, Saki Ameda, Michiko Yamada, Tomoyuki Abe, Shigeyuki Fujii, Miri Fujita, Masahiro Maeda
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2021-04-01 |
Deskripsi
Key Clinical Message The tumor reduction effect of pembrolizumab is extremely high compared to standard chemotherapy and might show prolonged survival. Therefore, the MSI status should be examined in patients with cholangiocarcinoma.